Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Martinetti

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Seminars in Surgical Oncology|June 9, 2001
Diagnostic and prognostic tumor markers in the gastrointestinal tractE Seregni, L Ferrari, A Martinetti, et al.
Revista Medica De Chile|October 1, 1992
[Phenytoin pharmacokinetics in young and older adults]J Estruch, D Galdames, A Martinetti, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 18, 2001
Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumorsE Seregni, A Martinetti, L Ferrari, et al.
Annales De Dermatologie Et De Venereologie|May 1, 1978
[Cutaneous periarteritis nodosa. Critical study about 4 cases (author's transl)]J Follana, Y Privat, A Martinetti, et al.
The International Journal of Biological Markers|May 16, 1998
Anti-malignin antibody evaluation: a possible challenge for cancer managementC Botti, A Martinetti, S Nerini-Molteni, et al.
Anticancer Research|January 12, 2000
The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumoursL Ferrari, E Seregni, E Bajetta, et al.
The International Journal of Biological Markers|November 6, 1998
Immunosuppressive factors: role in cancer development and progressionC Botti, E Seregni, L Ferrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Clinical significance of blood chromogranin A measurement in neuroendocrine tumoursE Seregni, L Ferrari, E Bajetta, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissuesC Recchione, E Venturelli, A Manzari, et al.
The International Journal of Biological Markers|May 16, 1998
Bladder cancer monitoring using two novel urinary markersC Botti, E Seregni, S Mattioli, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Seminars in Surgical Oncology|June 9, 2001
Diagnostic and prognostic tumor markers in the gastrointestinal tractE Seregni, L Ferrari, A Martinetti, et al.
Revista Medica De Chile|October 1, 1992
[Phenytoin pharmacokinetics in young and older adults]J Estruch, D Galdames, A Martinetti, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 18, 2001
Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumorsE Seregni, A Martinetti, L Ferrari, et al.
Annales De Dermatologie Et De Venereologie|May 1, 1978
[Cutaneous periarteritis nodosa. Critical study about 4 cases (author's transl)]J Follana, Y Privat, A Martinetti, et al.
The International Journal of Biological Markers|May 16, 1998
Anti-malignin antibody evaluation: a possible challenge for cancer managementC Botti, A Martinetti, S Nerini-Molteni, et al.
Anticancer Research|January 12, 2000
The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumoursL Ferrari, E Seregni, E Bajetta, et al.
The International Journal of Biological Markers|November 6, 1998
Immunosuppressive factors: role in cancer development and progressionC Botti, E Seregni, L Ferrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Clinical significance of blood chromogranin A measurement in neuroendocrine tumoursE Seregni, L Ferrari, E Bajetta, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissuesC Recchione, E Venturelli, A Manzari, et al.
The International Journal of Biological Markers|May 16, 1998
Bladder cancer monitoring using two novel urinary markersC Botti, E Seregni, S Mattioli, et al.
Pageof 6